After a successful completion of 11th International Virtual Seminar on COVID-19 Part II during December 16, 2020 and 7th International Virtual Seminar on COVID-19 Part I during August, 2020, we are initiating SciTech Central COVID-19 (18th World Seminar on COVID-19 & Vaccination) is a 2 day seminar scheduled on May 18-19, 2021 under the theme New Aspects of COVID-19 and it's Challenges. The interested speakers are requested to submit abstract and pre-recorded video of the talk. Speakers can be academicians, researchers, scientists, students, faculty members, healthcare executives, doctors etc. The exhibitors are invited to promote their healthcare products at our conference websites.
Many companies, organizations and research groups are making efforts towards development of effective human vaccine against this highly infectious disease caused by the SARS-CoV-2 coronavirus. A vaccine against SARS-CoV-2 should act against transmission, infection and disease. The major challnege for a vaccine is passing all the phases of Clinical Trials. The mutants of coronavirus is another challenge for the vaccine development. A vaccine for all age groups, genetype and adaptations is a big question for the scientists.
COVID-19 is a pandemic prevailing all across the world past few months. It has affected daily life of each individual, physically, economically or psychologically. The work and living style of all classes of society is changed. It is considered to be a positive change as an environmentalist, a struggle as a doctor, challenge as an economist, unsolved question as a scientist, scuffle as a law enforcement officer, fight for a healthcare worker, tussle for a government, psychological phase as a patient, and fear as a person. Universities are organizing Onlline Classes to assist students, scientists are working on clinical trials of vaccines, hospitalities are working on resuming travel with safety measures. This seminar invites all to share their experience and research through the video and take this opportunity in this lockdown.